Completed Pancreatic Diseases trials: Trial Insights

Filters: Condition: Pancreatic Diseases Status: Completed Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year
Category	Trials
2007	4
2008	1
2009	8
2010	3
2011	5
2012	2
2013	3
2014	4
2015	2
2016	6
2017	6
2018	7
2019	4
2020	8
2021	4
2022	6
2023	3
2024	1
2025	1

Trials by status
Category	Trials
Completed	78

Top lead sponsors
Category	Trials
Vertex Pharmaceuticals Incorporated	4
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	2
Boston Scientific Corporation	2
Helsinki University Central Hospital	2
Indiana University	2
Istituto Clinico Humanitas	2
Medizinische Hochschule Brandenburg Theodor Fontane	2
Memorial Sloan Kettering Cancer Center	2
Mylan Inc.	2
NanOlogy, LLC	2

Top conditions
Category	Trials
Pancreatic Diseases	78
Digestive System Diseases	22
Pancreatic Neoplasms	20
Cystic Fibrosis	14
Lung Diseases	13
Genetic Diseases, Inborn	11
Respiratory Tract Diseases	10
Digestive System Neoplasms	9
Pathologic Processes	7
Gallbladder Diseases	6

Trials

Showing 51 to 75 of 78. Each trial links to its page on Pharma Observatory.

Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) NCT01964430Phase 3CompletedCelgeneStarted 2014
Emergency Pancreaticoduodenectomy: a Non-trauma Center Case Series NCT05139394ObservationalCompletedIuliu Hatieganu University of Medicine and PharmacyStarted 2014
RCT: Difference in Diagnostic Yield Between EUSFNA Needles With and Without a Side Port in Pancreatic Masses NCT02092519Phase 4CompletedChangi General HospitalStarted 2013
89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients NCT01832116Phase 1CompletedUniversity Medical Center GroningenStarted 2013
Influence of Hospital Volume on Mortality and Length of Hospital Stay After Pancreatic Resection in Switzerland NCT07022639ObservationalCompletedCantonal Hospital of St. GallenStarted 2013
EUS Ductal Evaluation in One Endoscopic Session for the Diagnosis of Exocrine Pancreas Disease NCT01997476Not applicableCompletedIndiana UniversityStarted 2012
A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 NCT01608711Phase 2CompletedAgensys, Inc.Started 2012
Laparoscopy-assisted ERCP in Patients With Altered Gastric Anatome NCT01620632ObservationalCompletedUniversity of FloridaStarted 2011
Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency NCT01427725ObservationalCompletedMylan Inc.Started 2011
Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis NCT01427712ObservationalCompletedMylan Inc.Started 2011
Early (4 Days) Versus Standard Drainage of the Abdominal Cavity After Pancreaticoduodenectomy NCT01368094Not applicableCompletedCentre Hospitalier Universitaire, AmiensStarted 2011
Biospecimens for Identification of Diseases of the Pancreas. NCT01392027Not applicableCompletedUniversity of MichiganStarted 2011
Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas NCT01088815Phase 2CompletedSidney Kimmel Comprehensive Cancer Center at Johns HopkinsStarted 2010
Role of Patient Selection for Pancreatic Resections NCT06390891ObservationalCompletedMedizinische Hochschule Brandenburg Theodor FontaneStarted 2010
Total Pancreatectomies in Germany - Epidemiology, Trends, NCT06466928ObservationalCompletedMedizinische Hochschule Brandenburg Theodor FontaneStarted 2010
Risk of Methicillin-resistant S.Aureus (MRSA) Infections in MRSA Carrier Under Introduction of Rapid MRSA Screening NCT01918813Not applicableCompletedChikara TashiroStarted 2009
Safety and Efficacy of Inhaled OligoG CF-5/20 for the Treatment Cystic Fibrosis NCT00970346Phase 1CompletedAlgiPharma ASStarted 2009
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation NCT00909727Phase 3CompletedVertex Pharmaceuticals IncorporatedStarted 2009
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation NCT00909532Phase 3CompletedVertex Pharmaceuticals IncorporatedStarted 2009
Alfentanil Versus Remifentanil in Patient-controlled Sedation During Endoscopic Retrograde Cholangiopancreatography (ERCP) NCT01350037Phase 4CompletedHelsinki University Central HospitalStarted 2009
A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer NCT00902291Phase 2CompletedAstellas Pharma IncStarted 2009
Remote Ischemic Preconditioning In Abdominal Organ Transplantation NCT00975702Phase 3CompletedUniversity of Medicine and Dentistry of New JerseyStarted 2009
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation NCT00865904Phase 2CompletedVertex Pharmaceuticals IncorporatedStarted 2009
Drotaverine Hydrochloride Versus Hyoscine-N-butylbromide for Duodenal Antimotility During Endoscopic Retrograde Cholangiopancreatography (ERCP) NCT00731198Phase 3CompletedChanghai HospitalStarted 2008
A Study of Synthetic Human Secretin (ChiRhoStim®) Administered Intravenously to Stimulate Exocrine Pancreas Fluid Secretion for Collection Via Endoscope and Laboratory Analysis of DNA Markers NCT01087801Phase 3CompletedChiRhoClin, Inc.Started 2007

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.

Visit Pharma Observatory